IDEAYA Biosciences, Inc.
IDYA
$40.17
$0.220.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -112.45M | -98.54M | -83.27M | 119.24M | -77.49M |
| Total Depreciation and Amortization | 1.12M | 1.14M | 1.20M | 1.03M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.64M | 13.33M | 10.27M | 10.24M | 9.18M |
| Change in Net Operating Assets | 7.48M | 8.90M | -18.69M | 11.71M | 4.61M |
| Cash from Operations | -88.21M | -75.17M | -90.50M | 142.21M | -62.47M |
| Capital Expenditure | -866.00K | -967.00K | -333.00K | -42.00K | -663.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -155.07M | 119.92M | -97.19M | 41.81M | 46.58M |
| Cash from Investing | -155.93M | 118.95M | -97.53M | 41.77M | 45.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 218.20M | 1.19M | 2.13M | 301.00K | 1.21M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 141.01M | -9.00K | -- | -- | -- |
| Cash from Financing | 359.21M | 1.18M | 2.13M | 301.00K | 1.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.07M | 44.96M | -185.89M | 184.28M | -15.35M |